The concentration-dependent augmentation of FasL by sunitinib malate noted in our study suggests a possible involvement of the extrinsic apoptosis pathway in the antitumor action of the drug against TCC. This evidence concerns the gene FASLG and tarsal-carpal coalition syndrome.